Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells

Journal of Experimental Medicine

Volumn 184, Issue 1, 1996, Pages 19-29

  Groux, Hervé ^a   Bigler, Mike ^a   De Vries, Jan E ^a   Roncarolo, Maria Grazia ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CLONAL ANERGY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL;

ANTIGENS, CD28; CALCIUM; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CLONAL ANERGY; CYTOKINES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2; LYMPHOCYTE CULTURE TEST, MIXED; MONOCYTES; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 0030058433     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.1.19     Document Type: Article

References (45)

1. + T cell clones and peripheral blood T cells. J. Immunol. 149:2378-2384.
2. de Waal Malefyt, R., J. Haanen, H. Spits, M.G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J.E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915-924.
3. Macatonia, S.E., T.M. Doherty, S.C. Knight, and A. O'Garra. 1993. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J. Immunol. 150:3755-3765.
4. Caux, C., C. Massacrier, B. Vanbervliet, C. Barthelemy, Y.J. Liu, and J. Banchereau. 1994. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int. Immunol. 6:1177-1185.
5. Pecanha, L.M., C.M. Snapper, A. Lees, H. Yamaguchi, and J.J. Mond. 1993. IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro. J. Immunol. 150:3215-3223.
6. Ding, L., and E.M. Shevach. 1992. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 148:3133-3139.
7. Peguet-Navarro, J., C. Moulon, C. Caux, C. Dalbiez-Gauthier, J. Banchereau, and D. Schmitt. 1994. Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells. Eur J. Immunol. 24:884-891.
8. Ding, L., P.S. Linsley, L.Y. Huang, R.N. Germain, and E.M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224-1234.
9. Willems, F., A. Marchant, J.P. Delville, C. Gerard, A. Delvaux, T. Velu, M. de Boer, and M. Goldman. 1994. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur. J. Immunol. 24:1007-1009.
10. Chang, C.H., M. Fume, and K. Taniaki. 1995. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10. Eur. J. Immunol. 25:394-398.
11. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immunol. 150:4754-4765.
12. Taga, K., H. Mostowski, and G. Tosato. 1993. Human interleukin-10 can directly inhibit T-cell growth. Blood. 81:2964-2971.
13. Bejarano, M.T., R. de Waal Malefyt, J.S. Abrams, M. Bigler, R. Bacchetta, J.E. de Vries, and M.G. Roncarolo. 1992. Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int. Immunol. 4:1389-1397.
14. Roncarolo, M.-G. 1995. Interleukin-10 and transplantation tolerance. In Interleukin-10. R. de Waal Malefyt and J. E de Vries, editors. R.G. Landes Company, Austin, TX 113-120.
15. Bacchetta, R., M. Bigler, J.L. Touraine, R. Parkman, P.A. Tovo, J. Abrams, R. de Waal Malefyt, J.E. de Vries, and M.G. Roncarolo. 1994. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 179:493-502.
16. De Silva, D.R., K.B. Urdahl, and M.K. Jenkins. 1991. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol. 147:3261-3267.
17. Jenkins, M.K., C.A. Chen, G. Jung, D.L. Mueller, and R.H. Schwartz, 1990. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144:16-22.
18. Schwartz, R.H. 1990. A cell culture model for T lymphocyte clonal anergy. Science (Wash. DC). 248:1349-1356.
19. Sloau-Lancaster, J., B.D. Evavold, and P.M. Alien. 1994. Th2 cell clonal anergy as a consequence of partial activation. J. Exp. Med. 180:1195-1205.
20. Herve, P., J. Wijdenes, J.P. Bergerat, P. Bordigoni, N. Milpied, J.Y. Cahn, C. Clement, R. Beliard, B. Morel-Fourrier, E. Racadot. et al., 1990. Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10). Blood. 75:1017-1023.
21. Spits, H., G. Keizer, J. Borst, C. Terhorst, A. Hekman, and J.E. de Vries. 1983. Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activity of natural and activated killer cells and cloned CTL lines. Hybridoma. 4:423-137.
22. Yssel, H., J.E. De Vries, M. Koken, W. Van Blitterswijk, and H Spits. 1984. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J. Immunol. Methods. 72:219-227.
23. Bacchetta, R., R. Parkman, M. McMahon, K. Weinberg, M. Bigler, J.E. de Vries, and M.G. Roncarolo. 1995. Dysfunctional cytokine production by host-reactive T-cell clones isolated from a chimeric severe combined immunodeficiency patient transplanted with haploidentical bone marrow. Blood. 85:1944-1953.
24. Jenkins, M.K. 1992. The role of cell division in the induction of clonal anergy. Immunol. Today. 132:69-73.
25. Boussiotis, V.A., G.J. Freeman, J.D. Griffin, G.S. Gray, J.G. Gribben, and L.M. Nadler. 1994. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy. J. Exp. Med. 180:1665-1673.
26. Lamb, J.R., B.J. Skidmore, N. Green, J.M. Chiller, and M. Feldmann. 1983. Induction of tolerance in influenza virus immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J. Exp. Med. 157:1434-1447.
27. Fasler, S., G. Aversa, A. Terr, K. Thestrup-Petersen, J.E. de Vries, and H. Yssel. 1995. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and 13 cell help for IgE synthesis. J. Immunol. 155: 4248-4254.
28. Suzuki, G., M. Noniura, A. Uzawa, M. Akashi, and Y. Nakata. 1995. Impaired CD28-mediated co-stimulation in anergic T cells. Int. Immunol. 71:37-43.
29. Ramsdell, F., and B.J. Fowlkes. 1992. Maintenance of in vivo tolerance by persistence of antigen. Science (Wash. DC). 257: 1130-1134.
30. Groux, H., D. Monte, B. Plouvier, A. Capron, and J.C. Ameisen. 1993. CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-gamma and accessory cells. Eur. J. Immunol. 23:1623-1629.
31. Kang, S.M., B. Beverly, A.C. Tran, K. Brorson, R.H. Schwartz, and M.J. Lenardo. 1992. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science (Wash. DC). 257:1134-1138.
32. + T cells. Science (Wash. DC). 271:1276-1278.
33. + T cells. Science (Wash. DC). 271: 1272-1275.
34. + T cells. J. Immunol. 151:2355-2367.
35. Dallman, M.J., K.J. Wood, K. Hamano, A.R. Bushell, P.J. Morris, M.J. Wood, and H.M. Charlton. 1993. Cytokines and peripheral tolerance to alloantigen. Immunol. Rev. 133:5-18.
36. Rocken, M., J.F. Urban, and E.M. Shcvach. 1992. Infection breaks T-cell tolerance. Nature (Lond.). 359:79-82.
37. Lenschow, D.J., and J.A. Bluestone. 1993. T cell co-stimulation and in vivo tolerance. Curr. Opin. Immunol. 5:747-752.
38. Linsley, P.S., P.M. Wallace, J. Johnson, M.G. Gibson, J.L. Greene, J.A. Ledbetter, C. Singh, and M.A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science (Wash. DC). 257:5071: 792-795.
39. Charlton, B., R.H. Guymer, R.M. Slattery, and T.E. Mandel. 1991. Intercellular adhesion molecule (ICAM-1) inhibition can induce tolerance in vivo. Immunol. Cell Biol. 692: 89-93.
40. Nakao, A., H. Nakajima, H. Tomioka, T. Nishimura, and I. Iwamoto. 1994. Induction of T cell tolerance by pretreatment with anti-ICAM-1 and anti-lymphocyte function-associated antigen-1 antibodies prevents antigen-induced eosino-phil recruitment into the mouse airways. J. Immunol. 153: 5819-5825.
41. Miller, G.T., P.S. Hochman, W. Meier, R. Tizard, S.A. Bixler, M.D Rosa, and B.P. Wallner. 1993. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses. J. Exp. Med. 178:211-222.
42. Tivol, E.A., F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541-547.
43. Roncarolo, M.G., H. Yssel J.L. Touraine, H. Betuel, J.E. De Vries, and H. Spits. 1988. Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera. J Exp. Med. 167:1523-1534.
44. Bacchetta, R., B.A. Vandekerckhove, J.L. Touraine, M. Bigler, S. Martino, L. Gebuhrer, J.E. de Vries, H. Spits, and M.G. Roncarolo. 1993. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells. J. Clin. Invest. 91:1067-1078.
45. Holler, E., M.-G. Roncarolo, R. Hintermeierknabe, B. Ertl, E. Rustige, M. Albiez, H.J. Kolb, and W. Wilmanns. 1995. Systemic and cellular-release of IL-10 in human BMT. Eur. J. Cancer. 31:39-45.